Kyle Steiger
Corporate Officer/Principal presso VALEO PHARMA INC.
Patrimonio netto: 1 261 $ in data 30/04/2024
Profilo
Kyle Steiger is a professional who currently holds the position of Chief Commercial Officer & Senior Vice President at Valeo Pharma, Inc. Prior to this, he worked as VP-Ophthalmology, Primary Care & Franchise at Novartis Pharmaceuticals Canada, Inc. and as Vice President-Commercial Services at Ashfield Healthcare Canada, Inc. He completed his undergraduate degree at Brock University.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
VALEO PHARMA INC CLASS A
0.02% | 29/11/2023 | 19 394 ( 0.02% ) | 1 261 $ | 30/04/2024 |
Posizioni attive di Kyle Steiger
Società | Posizione | Inizio |
---|---|---|
VALEO PHARMA INC. | Corporate Officer/Principal | 30/08/2022 |
Precedenti posizioni note di Kyle Steiger
Società | Posizione | Fine |
---|---|---|
Novartis Pharmaceuticals Canada, Inc.
Novartis Pharmaceuticals Canada, Inc. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Canada, Inc. manufactures chemicals and pharmaceuticals products. It provides solutions on patients suffering from a variety of major illnesses including cancer, cardiovascular diseases, Alzheimer's disease, age-related macular degeneration, organ transplantation, and osteoporosis. The company was founded in 1996 and is headquartered in Dorval, Canada. | Corporate Officer/Principal | - |
Ashfield Healthcare Canada, Inc. | Corporate Officer/Principal | - |
Formazione di Kyle Steiger
Brock University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
VALEO PHARMA INC. | Health Technology |
Aziende private | 2 |
---|---|
Novartis Pharmaceuticals Canada, Inc.
Novartis Pharmaceuticals Canada, Inc. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Canada, Inc. manufactures chemicals and pharmaceuticals products. It provides solutions on patients suffering from a variety of major illnesses including cancer, cardiovascular diseases, Alzheimer's disease, age-related macular degeneration, organ transplantation, and osteoporosis. The company was founded in 1996 and is headquartered in Dorval, Canada. | Health Technology |
Ashfield Healthcare Canada, Inc. |
- Borsa valori
- Insiders
- Kyle Steiger